Millennium Management’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-387,567
Closed -$8.38M 7337
2022
Q4
$8.38M Sell
387,567
-123,910
-24% -$2.62M ﹤0.01% 2322
2022
Q3
$9.9M Buy
511,477
+479,023
+1,476% +$9.91M 0.01% 2148
2022
Q2
$645K Sell
32,454
-28,400
-47% -$749K ﹤0.01% 4751
2022
Q1
$1.81M Sell
60,854
-157,145
-72% -$4.6M ﹤0.01% 3983
2021
Q4
$5.08M Sell
217,999
-39,918
-15% -$1.06M ﹤0.01% 2893
2021
Q3
$8.05M Buy
257,917
+26,363
+11% +$816K ﹤0.01% 2333
2021
Q2
$8.15M Buy
231,554
+15,932
+7% +$518K 0.01% 2158
2021
Q1
$7.6M Sell
215,622
-37,847
-15% -$1.4M 0.01% 2093
2020
Q4
$9.51M Sell
253,469
-19,797
-7% -$720K 0.01% 1791
2020
Q3
$9.12K Buy
+273,266
New +$7.96M 0.01% 1342
2018
Q4
Sell
-66,035
Closed -$2.18M 4321
2018
Q3
$2.18M Sell
66,035
-37,981
-37% -$1.24M ﹤0.01% 2380
2018
Q2
$3.69M Sell
104,016
-51,595
-33% -$1.67M ﹤0.01% 2001
2018
Q1
$5.07M Buy
155,611
+109,017
+234% +$3.67M 0.01% 1800
2017
Q4
$1.19M Buy
46,594
+18,425
+65% +$467K ﹤0.01% 2590
2017
Q3
$590K Sell
28,169
-1,814
-6% -$43.3K ﹤0.01% 2765
2017
Q2
$618K Buy
+29,983
New +$615K ﹤0.01% 2702
2015
Q4
Sell
-1,532
Closed -$20K 3867
2015
Q3
$20K Sell
1,532
-3,840
-71% -$96.7K ﹤0.01% 3390
2015
Q2
$166K Buy
+5,372
New +$180K ﹤0.01% 3089
2014
Q2
Sell
-557
Closed -$46K 4013
2014
Q1
$46K Sell
557
-21,289
-97% -$1.94M ﹤0.01% 3360
2013
Q4
$1.49M Buy
21,846
+17,041
+355% +$1.25M ﹤0.01% 2032
2013
Q3
$454K Buy
+4,805
New +$626K ﹤0.01% 2613

Other funds holding ALBO

Millennium Management's ALBO Position: Q1 2023 in Review

Millennium Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 387,567 shares — an estimated $8.38M sold.

Millennium Management first reported a position in ALBO in Q3 2013 and held it in 21 quarters. The position peaked at $9.9M in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Millennium Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 387,567 Albireo Pharma Inc shares in Q1 2023, an estimated $8.38M.
  • Millennium Management first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 21 quarters.
  • Millennium Management's Albireo Pharma Inc position peaked at $9.9M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.